Activated cdc42‐associated kinase is up‐regulated in non‐small‐cell lung cancer and necessary for FGFR‐mediated AKT activation

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Molecular Carcinogenesis

• Publication date

  2016-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mc.22327PMID 25945695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology of Lung Cancer.

  2016cited by this paper
• Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation

  2014cited by this paper
• Bosutinib inhibits migration and invasion via ack1 in kras mutant non-small cell lung cancer

  2014cited by this paper
• Lung cancer chemotherapy, new treatment and related patents.

  2014cited by this paper
• The non-receptor tyrosine kinase Ack1 regulates the fate of activated EGFR by inducing trafficking to the p62/NBR1 pre-autophagosome

  2014cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• Epidemiology of Lung Cancer

  2013cited by this paper
• Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer

  2012cited by this paper
• The activation mechanism of ACK1 (activated Cdc42-associated tyrosine kinase 1).

  2012cited by this paper
• Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells

  2010cited by this paper
• A chemical and phosphoproteomic characterization of dasatinib action in lung cancer

  2010cited by this paper
• Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI.

  2009cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer

  2009cited by this paper
• Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer.

  2009cited by this paper
• Down-regulation of Active ACK1 Is Mediated by Association with the E3 Ubiquitin Ligase Nedd4-2*

  2009cited by this paper
• The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer.

  2009cited by this paper
• EGFR-Mutationsanalyse beim nichtkleinzelligen Lungenkarzinom

  2009cited by this paper
• Cancer genomics and genetics of FGFR2 (Review).

  2008cited by this paper
• Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non‐small cell lung cancer

  2008cited by this paper
• Dysregulation of Ack1 inhibits down-regulation of the EGF receptor.

  2008influential reference
• Activated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation.

  2007cited by this paper
• Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation

  2007cited by this paper
• Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray.

  2006cited by this paper
• Ack1 Mediates Cdc42-dependent Cell Migration and Signaling to p130Cas*

  2006cited by this paper
• Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.

  2005cited by this paper
• Phosphotyrosine Signaling Networks in Epidermal Growth Factor Receptor Overexpressing Squamous Carcinoma Cells*S

  2005influential reference
• Requirement of Activated Cdc42-Associated Kinase for Survival of v-Ras-Transformed Mammalian Cells

  2005cited by this paper
• The new World Health Organization classification of lung tumours

  2001influential reference
• Epidermal growth factor stimulation of the ACK1/Dbl pathway in a Cdc42 and Grb2-dependent manner.

  2001cited by this paper
• Activation of the guanine nucleotide exchange factor Dbl following ACK1-dependent tyrosine phosphorylation.

  2000cited by this paper
• Stimulation of Ras Guanine Nucleotide Exchange Activity of Ras-GRF1/CDC25Mm upon Tyrosine Phosphorylation by the Cdc42-regulated Kinase ACK1*

  2000cited by this paper
• A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42

  1993cited by this paper
• Cancer statistics

  1989cited by this paper

• RFX2-BNIP3 axis-driven adaptive mitophagy promotes resistance to ACK1-targeted therapy in non-small cell lung cancer

  2025cites this paper
• ACK1/TNK2 kinase: molecular mechanisms and emerging cancer therapeutics.

  2024cites this paper
• Improvement of ACK1-targeted therapy efficacy in lung adenocarcinoma using chloroquine or bafilomycin A1

  2023cites this paper
• Domain Architecture of the Nonreceptor Tyrosine Kinase Ack1

  2023cites this paper
• Identification of renal cyst cells of type I Nephronophthisis by single-nucleus RNA sequencing

  2023cites this paper
• FGF9 promotes cell proliferation and tumorigenesis in TM3 mouse Leydig progenitor cells.

  2022cites this paper
• Role of Activated Cdc42-Associated Kinase 1 (ACK1/TNK2)-Inhibitors in Precision Oncology

  2022cites this paper
• Proximity-dependent biotinylation to elucidate the interactome of TNK2 non-receptor tyrosine kinase

  2021cites this paper
• Small Molecules Targeting Activated Cdc42-Associated Kinase 1 (ACK1/TNK2) for the Treatment of Cancers.

  2021cites this paper
• Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer

  2020cites this paper
• Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer

  2020cites this paper
• Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib.

  2020cites this paper
• FGF signaling is required for chemokinesis and ventral migration of trunk neural crest cells

  2020cites this paper
• Could cell division cycle protein 42 be a target for lung cancer treatment?

  2019cites this paper
• Cadmium-induced genome-wide DNA methylation changes in growth and oxidative metabolism in Drosophila melanogaster

  2019cites this paper
• miR‑497 inhibits the proliferation and migration of A549 non‑small‑cell lung cancer cells by targeting FGFR1.

  2019cites this paper
• Research Progress of the Functional Role of ACK1 in Breast Cancer

  2019cites this paper
• Knockdown of activated Cdc42-associated kinase inhibits human extravillous trophoblast migration and invasion and decreases protein expression of pho-Akt and matrix metalloproteinase

  2018cites this paper
• FGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells

  2018cites this paper
• Amplification of ACK1 promotes gastric tumorigenesis via ECD-dependent p53 ubiquitination degradation

  2015cites this paper